ModivCare Inc Balance Sheet | Understand Stock

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

(Debtor-in-Possession) Unaudited Condensed Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021	Q4 FY2020 As of Dec 31, 2020
Assets
Current assets:
Cash and cash equivalents
Accounts receivable, net of allowance of $383 and $1,439, respectively
Contract receivables
Other receivables
Prepaid expenses and other current assets
Short-term deposits
Restricted cash
Current assets of discontinued operations
Total current assets

Property and equipment, net
Long-term contract receivables
Goodwill
Payor network, net
Other intangible assets, net
Equity investment
Operating lease right-of-use assets
Other assets
Total assets
Liabilities and stockholders' equity (deficit)
Current liabilities:
Current portion of long-term obligations
Accounts payable
Accrued contract payables
Accrued transportation costs
Accrued expenses and other current liabilities
Current portion of operating lease liabilities
Self-funded insurance programs
Deferred revenue
Current liabilities of discontinued operations
Revolving Credit Facility
Short-term debt
Debtor-in-possession facility
Total current liabilities

Long-term debt, net of deferred financing costs of $24,775 and $14,020, respectively
Long-term debt, net of deferred financing costs of $21,699 and $24,775, respectively
Long-term debt, net of deferred financing costs of $— and $30,689, respectively
Deferred tax liabilities
Long-term contract payables
Operating lease liabilities, less current portion
Other long-term liabilities
Liabilities subject to compromise
Total liabilities
Convertible preferred stock, net: Authorized 10,000,000 shares; $0.001 par value; 0 and 798,788 issued and outstanding; 5.5%/8.5% dividend rate
Stockholders’ equity (deficit)
Common stock: Authorized 40,000,000 shares; $0.001 par value; 19,927,526 and 19,882,026, respectively, issued and outstanding (including treasury shares)
Additional paid-in capital
Accumulated deficit
Treasury shares, at cost, 5,574,484 and 5,568,983 shares, respectively
Treasury shares, at cost, 5,525,915 and 5,558,898 shares, respectively
Total stockholders’ equity (deficit)

Total liabilities and stockholders’ equity (deficit)

Comments